Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mayo Clin Proc. 2012 Sep;87(9):879-89. doi: 10.1016/j.mayocp.2012.05.019.

Antiepileptic drugs 2012: recent advances and trends.

Author information

  • 1Department of Neurology, Division of Epilepsy, Mayo Clinic, Phoenix, AZ 85054, USA. sirven.joseph@mayo.edu

Abstract

There are now 24 antiepileptic drugs (AEDs) approved for use in epilepsy in the United States by the Food and Drug Administration. A literature search was conducted using PubMed, MEDLINE, and Google for all English-language articles that discuss newly approved AEDs and the use of AEDs in epilepsy in the United States from January 1, 2008, through December 31, 2011. Five new agents were identified that have come onto the market within the past 2 years. Moreover, 3 trends involving AEDs have become clinically important and must be considered by all who treat patients with epilepsy. These trends include issues of generic substitution of AEDs, pharmacogenomics predicting serious adverse events in certain ethnic populations, and the issue of the suicide risk involving the entire class of AEDs. This article discusses the most recent AEDs approved for use in the United States and the 3 important trends shaping the modern medical management of epilepsy.

Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

PMID:
22958992
[PubMed - indexed for MEDLINE]
PMCID:
PMC3538494
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk